Skip to Main Content

Paper Details

Potential of circulating tumor DNA as a predictor of therapeutic responses to immune checkpoint blockades in metastatic renal cell carcinoma.
Sci Rep
15
2021
40 genes, ICB, RCC, circulating, circulating tumor DNA, ctDNA, ctDNA samples, mRCC, metastatic renal cell carcinoma, patient, patients, plasma, primary tumors
Author NameAffiliation
Byong Chang JeongSamsung Medical Center, Sungkyunkwan University School of Medicine
Seong Il SeoSamsung Medical Center, Sungkyunkwan University School of Medicine
Hyun Moo LeeSamsung Medical Center, Sungkyunkwan University School of Medicine
Woong-Yang ParkSamsung Genome Institute, Samsung Medical Center
Woong-Yang ParkSungkyunkwan University School of Medicine
Woong-Yang ParkSamsung Genome Institute, Samsung Medical Center
Woong-Yang ParkSungkyunkwan University School of Medicine
  • 1 - 7

Datasets

Release 1.2